This corrects the article DOI: 10.1038/bmt.2012.225.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/bmt.2018.1 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Corrigendum to "Inhibition of HIF-2α expression in cardiomyocytes attenuates PCB126-induced cardiotoxicity associated with decreased apoptosis through the PI3K/Akt and p53 signaling pathways" [Ecotoxicol. Environ. Saf. 286 (2024) 117185].
Ecotoxicol Environ Saf
January 2025
Key Laboratory of Evidence Science (China University of Political Science and Law), Ministry of Education, Beijing, China.
Corrigendum to "Home infusion experience in patients with Pompe disease receiving avalglucosidase alfa during three clinical trials" [Molecular Genetics and Metabolism, 143 (2024) 108608].
Mol Genet Metab
January 2025
Center for Lysosomal and Metabolic Diseases, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
Corrigendum to "Genome-wide characterization of sugarcane catalase gene family identifies a ScCAT1 gene associated disease resistance" [Int. J. Biol. Macromol. 232 (2023) 123398].
Int J Biol Macromol
January 2025
Key Laboratory of Sugarcane Biology and Genetic Breeding, Ministry of Agriculture and Rural Affairs, National Engineering Research Center for Sugarcane, College of Agriculture, Fujian Agriculture and Forestry University, Fuzhou 350002, China. Electronic address:
Corrigendum to "Simultaneous post-neurosurgical ventriculitis and bacteraemia by two different strains of KPC-producing K. pneumoniae successfully treated with meropenem/vaborbactam and high dose of Fosfomycin" [Journal of Global Antimicrobial Resistance 37 (2024) 86-90].
J Glob Antimicrob Resist
January 2025
Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy. Electronic address:
Corrigendum to "Structure-based development of N-Arylindole derivatives as Pks13 inhibitors against Mycobacterium tuberculosis" [Europ. J. Med. Chem. 283 (2025) 117148].
Eur J Med Chem
January 2025
Shanghai Engineering Research Center of Molecular Therapeutics and New Drug Development, School of Chemistry and Molecular Engineering, East China Normal University, 3663 North Zhongshan Road, Shanghai, 200062, China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!